Arzeda, the Protein Design Company™, has secured $38 million in an oversubscribed funding round, attracting new investors like Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and W.L. Gore & Associates. Previous investors, including Continental Grain Company’s venture arm, Bunge Ventures, and Lewis & Clark Agrifood, also participated.

This fresh capital will support the expansion of Arzeda’s production of its ProSweet Enzymes™ and ProSweet RebM™ to meet the increasing demand for improved stevia products, while also speeding up the commercialization of new breakthrough products.

Arzeda’s collaborations with global leaders such as Unilever, AAK, and W.L. Gore & Associates will further push its products to market. According to Michael Krel, a partner at Sofinnova Partners, Arzeda’s industrial biotech products, including designer proteins and enzymes, are crucial for reducing greenhouse gas emissions.

He emphasized that Arzeda’s technology has reached commercial scale, enabling the company to offer real-world solutions across several industries.

Arzeda’s Intelligent Protein Design Technology™ is backed by one of the largest proprietary datasets of protein designs, using AI to develop more efficient proteins and enzymes.

These innovations surpass the performance of existing products across industries like food, agriculture, chemicals, and pharmaceuticals, while promoting sustainability. W.L. Gore’s Ed Rubin highlighted the strong environmental benefits of Arzeda’s next-generation materials, expressing excitement about deepening the partnership with the company.

Co-founder and CEO Alexandre Zanghellini reiterated the company’s vision of a future shaped by designed proteins and enzymes, stating that Arzeda has successfully overcome challenges in the rapidly growing field of protein design to deliver sustainable, scalable solutions.